News
Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...
Discover why Hims & Hers is leading the telehealth market with strong growth, a loyal user base, and expansion into new ...
Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today ...
6d
24/7 Wall St. on MSNBought $40,000 of Hims & Hers (HIMS) Stock on a YOLO – Is it Time to Sell?Key Points Hims & Hers is an exciting stock in the telehealth sector, but as a growth stock, it’s not for the faint of heart.
Hims & Hers is the newest darling disrupting the telemedicine space. While shares have jumped 157% over the last year, Wall ...
By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up ...
The E.U.'s universal healthcare policies make pharmaceuticals much more affordable relative to the U.S., meaning there could ...
Hims & Hers expanding in Europe with the purchase of London-based digital health platform ZAVA. The acquisition gives the ...
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results